Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2), announced $3.5 million… Read More
Seattle-based biotech company Lumen Bioscience, which manufactures proteins in algae, will expand its manufacturing operations to a former bakery in… Read More
Seattle-based health data company Truveta today announced $95 million in fresh funding and the addition of three new participating healthcare… Read More
Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to… Read More
Experimental compounds that alter RNA boost the effectiveness of immunotherapy drugs against cancer cells and could potentially extend their use… Read More